Two Percent of All Female Newborns in the United States Are at Risk of Getting Ovarian Cancer As many as 30,000 U.S. women will be diagnosed with ovarian cancer this year. In 2006,[...]
OvaRex® MAb is a monoclonal antibody – a biotech drug – designed to help the patient’s immune system recognize and more effectively fight ovarian cancer. OvaRex® MAb is given durin[...]
Ovarian cancer is an illness that progresses quickly. Discover why one female doctor calls a woman's ovaries her female balls, and her unique view on what they may be saying when t[...]